# Oxaliplatin

NDC: 68001-468
Generic name: Oxaliplatin
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20201209

FDA application: ANDA204368

## Active ingredients

- OXALIPLATIN: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-468"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-468
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6083405-9b45-4d2c-e053-2995a90ad9ef